Please use this identifier to cite or link to this item: http://hdl.handle.net/2445/126909
Full metadata record
DC FieldValueLanguage
dc.contributor.authorSan Juan, Rafael-
dc.contributor.authorViedma, Esther-
dc.contributor.authorChaves, Fernando-
dc.contributor.authorLalueza, Antonio-
dc.contributor.authorFortún, Jesús-
dc.contributor.authorLoza, Elena-
dc.contributor.authorPujol Rojo, Miquel-
dc.contributor.authorArdanuy Tisaire, María Carmen-
dc.contributor.authorMorales, Isabel-
dc.contributor.authorCueto, Marina de-
dc.contributor.authorResino Foz, Elena-
dc.contributor.authorMorales Cartagena, Alejandra-
dc.contributor.authorRico, Alicia-
dc.contributor.authorRomero, María P.-
dc.contributor.authorOrellana, María Ángeles-
dc.contributor.authorLópez Medrano, Francisco-
dc.contributor.authorFernández Ruiz, Mario-
dc.contributor.authorAguado, José María-
dc.date.accessioned2018-12-11T13:21:26Z-
dc.date.available2018-12-11T13:21:26Z-
dc.date.issued2016-06-
dc.identifier.issn1080-6040-
dc.identifier.urihttp://hdl.handle.net/2445/126909-
dc.description.abstractWe investigated the prognostic role of high MICs for antistaphylococcal agents in patients with methicillin-sensitive Staphylococcus aureus catheter-related bloodstream infection (MSSA CRBSI). We prospectively reviewed 83 episodes from 5 centers in Spain during April 2011 June 2014 that had optimized clinical management and analyzed the relationship between E-test MICs for vancomycin, daptomycin, oxacillin, and linezolid and development of complicated bacteremia by using multivariate analysis. Complicated MSSA CRBSI occurred in 26 (31.3%) patients; MICs for vancomycin and daptomycin were higher in these patients (optimal cutoff values for predictive accuracy = 1.5 mu g/mL and 0.5 mu g/mL). High MICs for vancomycin (hazard ratio 2.4, 95% CI 1.2-5.5) and daptomycin (hazard ratio 2.4, 95% CI 1.1-5.9) were independent risk factors for development of complicated MSSA CRBSI. Our data suggest that patients with MSSA CRBSI caused by strains that have high MICs for vancomycin or daptomycin are at increased risk for complications.-
dc.format.extent10 p.-
dc.format.mimetypeapplication/pdf-
dc.language.isoeng-
dc.publisherCenters for Disease Control and Prevention-
dc.relation.isformatofReproducció del document publicat a: https://doi.org/10.3201/eid2206.151709-
dc.relation.ispartofEmerging Infectious Diseases, 2016, vol. 22, num. 6, p. 1057-1066-
dc.relation.urihttps://doi.org/10.3201/eid2206.151709-
dc.rights, 2016-
dc.sourceArticles publicats en revistes (Patologia i Terapèutica Experimental)-
dc.subject.classificationSang-
dc.subject.classificationMalalties bacterianes-
dc.subject.classificationFactors de risc en les malalties-
dc.subject.classificationEfecte dels medicaments sobre els microorganismes-
dc.subject.otherBlood-
dc.subject.otherBacterial diseases-
dc.subject.otherRisk factors in diseases-
dc.subject.otherEffect of drugs on microorganisms-
dc.titleHigh MICs for Vancomycin and Daptomycin and Complicated Catheter-Related Bloodstream Infections with Methicillin-Sensitive Staphylococcus aureus-
dc.typeinfo:eu-repo/semantics/article-
dc.typeinfo:eu-repo/semantics/publishedVersion-
dc.identifier.idgrec662472-
dc.date.updated2018-12-11T13:21:26Z-
dc.rights.accessRightsinfo:eu-repo/semantics/openAccess-
dc.identifier.pmid27192097-
Appears in Collections:Articles publicats en revistes (Patologia i Terapèutica Experimental)
Articles publicats en revistes (Institut d'lnvestigació Biomèdica de Bellvitge (IDIBELL))

Files in This Item:
File Description SizeFormat 
662472.pdf1.55 MBAdobe PDFView/Open


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.